Answers are grounded in this paper and cite their sources.
GDF-15 fold change from baseline for dose-escalation cohorts receiving BI 907828 D1q3w and BI 907828 D1D8q4w
No takes yet. Share an insight, caveat, or question.
LoRusso et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: